ArticleJournal of preventive medicine and hygiene2018
Awareness and knowledge about cervical cancer prevention methods among Tunisian women.
Article in Journal of preventive medicine and hygiene, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.
- Cervical cancer screening uptake in Arab countries: a systematic review with meta-analysis.BMC cancer · 2024Pooled it
- Palliative interventions for controlling vaginal bleeding in advanced cervical cancer.The Cochrane database of systematic reviews · 2019Pooled it
- Evaluation of HPV awareness among parents of adolescent girls in Tunisia: a cross-sectional study.Scientific reports · 2026Article
- Impact of an Educational Intervention Video in HPV Prevention among Tunisian Female Students: A before-and-after Study.Journal of preventive medicine and hygiene · 2025Article
- Awareness of human papillomavirus and acceptability of the vaccine among women in Palestine: is it time for policy adjustment?BMC women's health · 2022Article
- Human Papillomavirus Knowledge and Vaccine Acceptability in Jazan Province, Saudi Arabia.Vaccines · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionEpidemiological and biological arguments put papillomavirus infection (HPV) as a determining factor in the etiology of cervical cancer. The main objective of this study is to assess the knowledge, attitudes and practices related to HPV prevention and cervical cancer screening among women living in the city of Sousse, Tunisia.
methodsFive hundred Tunisian women were interviewed face to face between May and June 2016. The questionnaire consisted in 14 questions relating participants' socio-demographic information, their awareness level, attitudes and practices regarding HPV and cervical cancer, including their understanding of the underlying cervical cancer etiology and preventive actions such as the Pap Smear test, and finally their acceptability and willingness to receive the anti-HPV vaccine under certain circumstances. Multivariate analyses were conducted to identify predictive factors of good acceptability of cervical cancer prevention methods.
resultsFour hundred fifty-two questionnaires were completed and included in the analysis. The awareness of a sexually transmitted infection as an etiological agent for cervical cancer was expressed by 175 (38.7%) participants, the correct finality of the Pap Smear test by 308 (68%) and its recommended frequency by 176 (38.9%) respondents. Among all participants, 125 (27.7%) had undertaken the Pap Smear test at least once in their lifetime, 363 (80.3%) were interested in receiving the anti-HPV vaccine for themselves, 387 (86%) for their daughters and 405 (90%) approved the introduction of the anti-HPV vaccine in the Tunisian national program of vaccination.
conclusionsThe knowledge and awareness of HPV infection and cervical cancer among Tunisian women was found to be moderate (around 40%) and the acceptability of the anti-HPV vaccine was found to be high (over 80%). These results are concordant with the results of other studies conducted in other MENA countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.